|
Carl Roth GmbH
dimethylsulfoxid (dmso) solvent control ![]() Dimethylsulfoxid (Dmso) Solvent Control, supplied by Carl Roth GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dmso+vehicle+control+solvent/dimethylsulfoxid++dmso++solvent+control/pmc12143595-33-4-9 Average 90 stars, based on 1 article reviews
dimethylsulfoxid (dmso) solvent control - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Carl Roth GmbH
dmso solvent control ![]() Dmso Solvent Control, supplied by Carl Roth GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dmso+vehicle+control+solvent/dmso+solvent+control/pm39779959-261-4-8 Average 90 stars, based on 1 article reviews
dmso solvent control - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Merck KGaA
dmso (solvent control) ![]() Dmso (Solvent Control), supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dmso+vehicle+control+solvent/dmso++solvent+control+/us11103504-179-41-44 Average 90 stars, based on 1 article reviews
dmso (solvent control) - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
SERVA Electrophoresis
solvent control (dmso) ![]() Solvent Control (Dmso), supplied by SERVA Electrophoresis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dmso+vehicle+control+solvent/solvent+control++dmso+/pmc10558604__BLOODA_ADV___2022___009652___mmc1-67-17-20 Average 90 stars, based on 1 article reviews
solvent control (dmso) - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
Ratiopharm gmbh
mic-determination control for solvent dmso and ciprofloxacin ![]() Mic Determination Control For Solvent Dmso And Ciprofloxacin, supplied by Ratiopharm gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/dmso+vehicle+control+solvent/mic+determination+control+for+solvent+dmso+and+ciprofloxacin/pm22682300-134-7-8 Average 90 stars, based on 1 article reviews
mic-determination control for solvent dmso and ciprofloxacin - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Nucleic Acids Research
Article Title: p53 reveals principles of chromatin remodeling and enhancer activation
doi: 10.1093/nar/gkaf465
Figure Lengend Snippet: p53 is a pioneer factor that increases DNA accessibility. ( A ) ATAC-seq was performed on four biological replicates of Nutlin-3a and DMSO control-treated MCF-7 cells. Accessible sites were identified by peak calling, and their differential accessibility was assessed. ( B ) Enrichment of transcription factor binding sites that overlap sites with increased (left) or decreased (right) accessibility upon Nutlin-3a treatment. The top 15 transcription factors are displayed. ( C ) The presence (open) or absence (closed) of an ATAC-seq peak has been assessed at 7705 recurrent p53 binding sites, and changes between the Nutlin-3a and DMSO control conditions are displayed. ( D ) p53 ChIP-seq and ATAC-seq signals are displayed for the groups identified in panel (C). Regions sorted by ATAC-seq signal. Genome browser images displaying p53 ChIP-seq and ATAC-seq data at a p53 binding site ( E ) that became accessible and ( F ) that remained inaccessible upon Nutlin-3a treatment. The predicted p53RE is highlighted. p53 ChIP-seq and nucleosome-free ATAC-seq data were normalized to CPM. Mono-nucleosome ATAC-seq data were normalized by DANPOS according to library size and accessible DNA background.
Article Snippet: Cells were treated with
Techniques: Control, Binding Assay, ChIP-sequencing
Journal: Nucleic Acids Research
Article Title: p53 reveals principles of chromatin remodeling and enhancer activation
doi: 10.1093/nar/gkaf465
Figure Lengend Snippet: p53 establishes enhancers. ( A ) p53 binding sites were sorted by local chromatin state (promoter, enhancer, transcription, quiescent). In addition, they were sorted by the presence (open) or absence (closed) of an ATAC-seq peak in Nutlin-3a and DMSO control conditions. ( B ) CUT&Tag for H3K4me1 and H3K27ac was performed on two biological replicates of Nutlin-3a and DMSO control-treated MCF-7 cells. H3K4me1, H3K27ac, ATAC-seq, and p53 ChIP-seq signals are displayed for p53 binding sites that were closed in the DMSO control condition and open ( C ) or closed ( D ) in the Nutlin-3a treatment condition. Regions were sorted by average signal and p53 binding sites located in promoters were removed for visualization purposes because of the small group size and different signal scales. ( E ) p53 occupancy (CPM) at p53 binding sites in the different groups. Significance determined using a two-tailed Kruskal–Wallis test. *** P -value <.001.
Article Snippet: Cells were treated with
Techniques: Binding Assay, Control, ChIP-sequencing, Two Tailed Test
Journal: Nucleic Acids Research
Article Title: p53 reveals principles of chromatin remodeling and enhancer activation
doi: 10.1093/nar/gkaf465
Figure Lengend Snippet: p53-induced transcription correlates with chromatin remodeling and requires high p53 abundance. ( A ) CAGE-seq was performed on four biological replicates of Nutlin-3a and DMSO control-treated MCF-7 cells. Significantly differentially regulated TSSs were identified. ( B ) Enrichment of transcription factor binding sites at sites with increased (left) or decreased (right) TSS activity upon Nutlin-3a treatment. The top 15 transcription factors are displayed. ( C ) Comparison of changes in TSS activity (CAGE-seq) and DNA accessibility (ATAC-seq) for all TSSs in accessible DNA regions (determined by ATAC-seq peaks) upon Nutlin-3a treatment. ( D ) Subsets of TSSs/accessible sites that overlap with p53 (top panel), E2F4 (middle panel), and RFX7 binding sites (bottom panel). ( E ) p53 ChIP-seq, ATAC-seq, H3K4me1, and H3K27ac signals at p53 binding sites located in promoter regions. Subgroups were determined by overlaps with an induced TSS (log 2 FC > 0.5), uninduced TSS (log 2 FC < 0.5), and no TSS. Regions sorted by H3K27ac signal. ( F ) Comparison of changes in local transcription (CAGE-seq) and p53 occupancy (CPM from ChIP-seq). Significance determined by two-tailed Spearman correlation. Sigmoidal fit obtained best r 2 . ( G ) The fraction of promoter p53 binding sites with a canonical p53RE, noncanonical p53RE, and no p53RE.
Article Snippet: Cells were treated with
Techniques: Control, Binding Assay, Activity Assay, Comparison, ChIP-sequencing, Two Tailed Test
Journal: Nucleic Acids Research
Article Title: p53 reveals principles of chromatin remodeling and enhancer activation
doi: 10.1093/nar/gkaf465
Figure Lengend Snippet: p53 preferentially directs transcription initiation to the p53RE and other sites within 100 bp. ( A ) Positional p53 motif enrichment relative to the CAGE-seq-detected TSS (CTSS) identified by HOMER2. The density of CTSSs at ±200 bp around canonical p53REs of p53 binding sites in ( B ) Nutlin-3a and DMSO control samples and ( C ) the Nutlin-3a data separated by EpiMap-derived chromatin states. ( D ) Genome browser images displaying CAGE-seq data among p53 ChIP-seq, ATAC-seq, and CUT&Tag (H3K4me1 and H3K27ac) data at two p53 binding sites. The predicted p53RE is highlighted. p53 ChIP-seq, nucleosome-free ATAC-seq, and CUT&Tag data were normalized to CPM. Mono-nucleosome ATAC-seq data were normalized by DANPOS. CTSSs were coverage normalized. ( E ) Dynamic p53 binding is required for Pol II initiation after its recruitment to the edges of nucleosome-depleted regions.
Article Snippet: Cells were treated with
Techniques: Binding Assay, Control, Derivative Assay, ChIP-sequencing